Events

Safety Alert for Lucentis needle

According to Health Ministry (Panama), this safety alert involved a device in Panama that was produced by Novartis.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event Date Posted
    2011-03-28
  • Event Country
    Panama
  • Event Source
    HMP
  • Event Source URL
    http://www.minsa.gob.pa/informacion-salud/alertas-y-comunicados?title=&field_decree_date_value%5Bvalue%5D%5Byear%5D=2011
  • Notes / Alerts
    Panamanian data is current through January 2019. All of the data comes from the Health Ministry (Panama), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Panama.
  • Extra notes in the data

Device

Lucentis needle
  • Model / Serial
  • Product Description
    Lucentis®, commercial product whose active substance corresponds to Rabinizumab, a fragment of humanized monoclonal antibody produced in Escherichia coli cells by technology of recombinant DNA.
  • Manufacturer
    Novartis

Manufacturer

Novartis